These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 24678769)

  • 21. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M; Międzybrodzki R; Drulis-Kawa Z; Cater K; Knežević P; Winogradow C; Amaro K; Jończyk-Matysiak E; Weber-Dąbrowska B; Rękas J; Górski A
    J Biomed Sci; 2022 Mar; 29(1):23. PubMed ID: 35354477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phage therapy for respiratory infections.
    Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
    Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
    Dąbrowska K; Abedon ST
    Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes.
    Green SI; Clark JR; Santos HH; Weesner KE; Salazar KC; Aslam S; Campbell JW; Doernberg SB; Blodget E; Morris MI; Suh GA; Obeid K; Silveira FP; Filippov AA; Whiteson KL; Trautner BW; Terwilliger AL; Maresso A
    Clin Infect Dis; 2023 Oct; 77(8):1079-1091. PubMed ID: 37279523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phage therapy of wound-associated infections.
    Zyman A; Górski A; Międzybrodzki R
    Folia Microbiol (Praha); 2022 Apr; 67(2):193-201. PubMed ID: 35028881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018.
    Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY
    J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biofilm control with natural and genetically-modified phages.
    Motlagh AM; Bhattacharjee AS; Goel R
    World J Microbiol Biotechnol; 2016 Apr; 32(4):67. PubMed ID: 26931607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
    Kakasis A; Panitsa G
    Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phage therapy, an alternative to antibiotic therapy?)].
    Reina J; Reina N
    Rev Esp Quimioter; 2018 Apr; 31(2):101-104. PubMed ID: 29451376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propagation, Purification, and Characterization of Bacteriophages for Phage Therapy.
    Kosznik-Kwaśnicka K; Topka G; Mantej J; Grabowski Ł; Necel A; Węgrzyn G; Węgrzyn A
    Methods Mol Biol; 2024; 2738():357-400. PubMed ID: 37966610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naturally-occurring and cultured bacteriophages in human therapy.
    Kiani AK; Anpilogov K; Dhuli K; Paolacci S; Benedetti S; Manara E; Guerri G; Dautaj A; Beccari T; Dundar M; Bertelli M
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(1 Suppl):101-107. PubMed ID: 34890040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections.
    Bodier-Montagutelli E; Morello E; L'Hostis G; Guillon A; Dalloneau E; Respaud R; Pallaoro N; Blois H; Vecellio L; Gabard J; Heuzé-Vourc'h N
    Expert Opin Drug Deliv; 2017 Aug; 14(8):959-972. PubMed ID: 27776446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriophage Infections of Biofilms of Health Care-Associated Pathogens:
    Santiago AJ; Donlan RM
    EcoSal Plus; 2020 Oct; 9(1):. PubMed ID: 33118486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulation strategies for bacteriophages to target intracellular bacterial pathogens.
    Yan W; Banerjee P; Xu M; Mukhopadhyay S; Ip M; Carrigy NB; Lechuga-Ballesteros D; To KKW; Leung SSY
    Adv Drug Deliv Rev; 2021 Sep; 176():113864. PubMed ID: 34271022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental Evolution of the TolC-Receptor Phage U136B Functionally Identifies a Tail Fiber Protein Involved in Adsorption through Strong Parallel Adaptation.
    Burmeister AR; Tzintzun-Tapia E; Roush C; Mangal I; Barahman R; Bjornson RD; Turner PE
    Appl Environ Microbiol; 2023 Jun; 89(6):e0007923. PubMed ID: 37191555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New perspectives of the phage therapy].
    Eyer L; Pantůcek R; Růzicková V; Doskar J
    Klin Mikrobiol Infekc Lek; 2007 Dec; 13(6):231-5. PubMed ID: 18320502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Customised infectiology - Phage therapy: from theory to clinical evidence].
    Desgranges F; Bochud PY; Resch G
    Rev Med Suisse; 2019 Apr; 15(646):771-775. PubMed ID: 30969489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.